Benjamin Ellingson, a professor of radiology and psychiatry in the David Geffen School of Medicine at UCLA and member of the UCLA Jonsson Comprehensive Cancer Center, has received a Defense Department Idea grant to develop a new non-invasive imaging method for quantifying metabolic activity within brain tumors.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
